BRIEF published on 11/06/2025 at 13:05, 4 months 12 days ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
PRESS RELEASE published on 11/06/2025 at 13:00, 4 months 12 days ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 4 months 15 days ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
BRIEF published on 11/03/2025 at 13:05, 4 months 15 days ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE published on 11/03/2025 at 13:00, 4 months 15 days ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 4 months 26 days ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 4 months 26 days ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 4 months 26 days ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 4 months 26 days ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
BRIEF published on 10/23/2025 at 13:05, 4 months 26 days ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
Published on 03/19/2026 at 01:05, 5 hours 8 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 6 hours 28 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 9 hours 13 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 11 hours 8 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 12 hours 3 minutes ago Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures
Published on 03/19/2026 at 06:05, 8 minutes ago Global terrorism falls to a decade low but Western fatalities surge
Published on 03/19/2026 at 03:50, 2 hours 23 minutes ago AWE2026 Signals the Future: A Defining Moment for the Age of AI
Published on 03/18/2026 at 22:00, 8 hours 13 minutes ago aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
Published on 03/18/2026 at 18:53, 11 hours 20 minutes ago EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 11 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 19:41, 10 hours 32 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 19:41, 10 hours 32 minutes ago Covivio - Modalités de mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/18/2026 at 19:36, 10 hours 37 minutes ago Covivio Hotels - Modalités de mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/18/2026 at 18:00, 12 hours 13 minutes ago Communiqué de presse – Résultats annuels 2025
Published on 03/18/2026 at 18:00, 12 hours 13 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
